🇺🇸

US SEC Filing Intelligence

· daily

General Federal Contracts — June 24, 2026

This digest covers 9 federal contracts totaling $834.7 million, with only 1 defense-related award (SAIC's $81.5M NITES contract with GSA FEDSIM, supporting NORAD/USNORTHCOM), underscoring a heavy civilian agency tilt. The Department of Health and Human Services (Leidos, $167M) and NASA (Caltech, $107.7M) dominate the top two awards, while SAIC appears twice ($159.1M combined from VA and GSA), signaling its growing IT services footprint. The highest-conviction signal is SAIC's two bullish-rated wins, both with low-to-medium pricing risk and multi-year revenue visibility. A key risk is the QTC Medical Services contract (Leidos subsidiary) with only $878K outlaid against a $93.6M obligation, suggesting potential execution delays or funding uncertainty.

9 total filings
· daily

All NASA Contracts — June 24, 2026

The single NASA contract awarded to the California Institute of Technology (Caltech) for $107.7 million (up to $111M ceiling) for the SPHEREx mission represents a pure civilian space science investment with no defense overlap. The cost-no-fee structure eliminates profit for Caltech, making this a neutral signal for equity investors despite the large dollar value. The key takeaway is NASA’s continued commitment to astrophysics missions, but the lack of profit margin and the fact that $93.5M has already been disbursed limit near-term financial impact. The primary risk is that this contract provides no direct revenue upside for publicly traded companies, and the competitive award suggests no single contractor has a durable moat in this niche.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — June 24, 2026

The 13 filings reveal a mixed picture for the S&P 500 Technology sector. Micron Technology reported record revenue of $41.46B (+346% YoY) driven by AI memory demand, with strong guidance for Q4. However, insider selling activity is widespread: Datadog's CTO sold $3.28M, Palo Alto Networks' CFO sold $609K, Arista's CTO sold $769K, and multiple Snowflake executives sold or had shares withheld for taxes. Qualcomm announced a stock-based acquisition of Modular Inc. (up to 19.2M shares), signaling M&A activity. Overall, the sector shows robust growth but insider selling raises caution.

12 high priority 1 medium 13 total filings
· daily

Nasdaq 100 Stocks SEC Filings — June 24, 2026

The three NASDAQ-100 filings for June 24, 2026, reveal a stark divergence between the surging AI-driven memory cycle and more measured corporate activity elsewhere. Micron Technology's record fiscal Q3 results dominate the stream, with revenue exploding 346% YoY to $41.46B and net income surging to $28.24B, driven by AI memory demand across its Cloud, Data Center, and Mobile segments. However, forward guidance for Q4 revenue of $50.0B implies a sequential growth deceleration to ~21% from 74%, signaling the peak of the current cycle may be approaching. Qualcomm's acquisition of Modular Inc. for up to 19.2 million shares represents a strategic but non-disruptive move into new technology, with no financial terms disclosed, suggesting a measured capital allocation approach. In contrast, a small insider sale by Intuit Director Richard Dalzell ($74.5K under a 10b5-1 plan) is a low-materiality event that does not alter the company's fundamental outlook. The portfolio-level pattern is one of extreme AI-driven outperformance in memory/storage versus more normalized activity in other tech subsectors.

2 high priority 1 medium 3 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — June 24, 2026

The June 24, 2026 batch of 35 filings reveals a surge in activist and insider activity, with notable board changes, take-private proposals, and significant insider buying. Key themes include activist investors accumulating stakes in undervalued companies (e.g., Cevian in Smith & Nephew, Farallon in Centessa), insider purchases signaling confidence (e.g., John Malone in Liberty Latin America, James Dahl in AMREP), and several complete exits by institutional investors (e.g., Pacific Ridge from Sleep Number, AltraVue from Yatra Online). The most material developments include a non-binding take-private bid for InMode at $16.20/share, a cooperation agreement at CEA Industries granting activist board seats, and a lawsuit filed against Brera Holdings. Period-over-period trends show mixed insider sentiment, with some insiders buying aggressively at lower prices while others exit entirely. The overall market implication is heightened event-driven opportunities, particularly in small- and mid-cap names with activist involvement.

19 high priority 16 medium 35 total filings
· daily

S&P 500 Financials Sector SEC Filings — June 24, 2026

The S&P 500 Financials sector is experiencing a wave of positive capital actions following the Federal Reserve's 2026 stress test results, with Morgan Stanley and U.S. Bancorp announcing dividend increases and share repurchase programs. Morgan Stanley stands out with a 15% dividend hike and a $20 billion buyback authorization, while U.S. Bancorp's more modest 3.8% dividend increase reflects a conservative approach. Insider activity at Aflac shows a director selling shares after exercising options, signaling potential profit-taking. JPMorgan Chase disclosed DFAST results and a separate press release on capital matters, but without quantitative details. Goldman Sachs filed a routine 8-K on preferred securities, and Wells Fargo Commercial Mortgage Trust issued $1.5B in CMBS. Overall, the sector shows strong capital return momentum, but insider selling at Aflac warrants caution.

2 high priority 5 medium 7 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — June 24, 2026

The two filings in this Consumer Staples digest present contrasting signals: insider selling at Hershey and a leadership transition at Molson Coors. Hershey's 10% owner, the Hershey Trust, sold approximately $895K in stock under a 10b5-1 plan, a negative sentiment signal that may reflect portfolio rebalancing rather than operational concern, given the low materiality. Molson Coors disclosed that its EMEA&APAC CEO is temporarily stepping away for medical reasons, a neutral-to-slightly-negative event that introduces short-term leadership uncertainty in a key growth region. No period-over-period financial data, forward guidance, or capital allocation changes were reported in either filing, limiting the depth of trend analysis. The sector themes are muted, with no cross-cutting patterns emerging from the limited data. Investors should monitor Hershey for further insider selling patterns and Molson Coors for updates on the CEO's return and regional performance.

2 high priority 2 total filings
· daily

S&P 500 Industrials Sector SEC Filings — June 24, 2026

The two filings in the S&P 500 Industrials stream present a sharp contrast in capital allocation strategy and operational performance. Republic Services is executing a large-scale debt financing ($1.2B), signaling a potential M&A or capex cycle, while Paychex, despite strong double-digit revenue growth (12% YoY in Q4), shows margin compression (GAAP operating margin down 100 bps to 38.6%) and a significant deceleration in EPS growth (7% FY vs 43% Q4). Paychex's forward guidance of 5-6% revenue growth implies a material slowdown from the 17% FY2026 pace, creating a cautious outlook. The key portfolio-level theme is a divergence between aggressive capital raising (Republic Services) and a post-acquisition integration phase with slowing momentum (Paychex). Insider activity data was not available in either filing, limiting conviction signals from management.

2 medium 2 total filings
· daily

S&P 500 Energy Sector SEC Filings — June 24, 2026

Over the June 24, 2026, reporting window for the S&P 500 Energy sector, insider trading activity in the two filings reveals a sharply divergent management sentiment. Baker Hughes Co (BKR) shows a strong bearish signal with its CEO executing a $10.6 million stock sale under a 10b5-1 plan following a discounted option exercise, netting a $3.55M profit. Conversely, Occidental Petroleum Corp (OXY) displays a bullish signal with its CEO making a $250,000 open-market purchase, increasing his stake at the current price. This dichotomy suggests a sector-wide tug-of-war between company-specific outlooks. There is no period-over-period financial data (revenue, margins) in these filings to establish trends, but the insider activity alone provides a high-conviction, actionable signal for investors to differentiate between these two major energy names. The lack of forward-looking guidance, M&A, and capital allocation data from other files limits broader sector thematic synthesis.

2 high priority 2 total filings
· daily

US Material Events SEC 8-K Filings — June 24, 2026

The June 24, 2026, filings reveal a market intensely focused on capital deployment and strategic repositioning. A dominant theme is the pivot toward AI and data center infrastructure, highlighted by Hyperscale Data's $1.2B+ MSA for AI compute capacity and FuelCell Energy's 380 MW agreement for data center power, signaling a massive wave of capital expenditure. Concurrently, the SPAC market is active, with three new IPOs (Wilco 63, Texas Ventures IV, Gores Holdings XI) raising $662M, and a major de-SPAC announced for Agility Robotics at a $2.5B valuation, reflecting sustained appetite for high-growth tech. The M&A landscape is bifurcated, with strategic acquisitions in community banking (Colony Bankcorp's $163M deal) and digital evidence (ROC's acquisition of ZTC), alongside a distressed restructuring (Compass Diversified's Lugano settlement). Capital markets remain a key funding source, with several biotechs (Absci, uniQure) and tech firms (GD Culture Group) raising capital, though often at the cost of significant dilution. Insider activity is muted, with no major buying or selling patterns detected, but several C-suite departures (Elastic, Grove Collaborative, BellRing Brands) signal ongoing organizational flux. Overall, the digest points to a market aggressively funding AI and infrastructure plays while managing legacy exposures and balance sheet restructuring.

50 high priority 50 total filings
· daily

Insider Trading Pulse — June 24, 2026

The June 24, 2026 insider trading digest reveals a pronounced bearish tilt, with 11 open-market sales versus only 6 open-market purchases, a ratio of nearly 2:1. The most significant insider activity is concentrated in the biotechnology and technology sectors, where multiple C-suite executives at Relay Therapeutics, Maze Therapeutics, and Twist Bioscience executed large, pre-planned sales, often following option exercises that locked in substantial gains. However, a notable contrarian signal emerges from American Shared Hospital Services, where the Executive Chairman made a massive $1.34M open-market purchase, signaling strong conviction at a depressed price. The day was also marked by a wave of equity awards (18 filings) and option dispositions related to corporate actions at Centessa Pharmaceuticals, which are neutral events but highlight significant insider holdings. Overall, the data suggests a cautious posture among corporate insiders, particularly in high-growth names, while select value-oriented purchases offer potential alpha opportunities.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — June 24, 2026

The 50 filings reviewed for the Global High Priority Market Events stream on June 24, 2026, reveal a market rife with governance failures, insider distress, and a wave of minority-buyout offers that signal deep structural concerns. The most critical headline is the negative audit from Vikas Lifecare, flagging material fraudulent transactions and regulatory non-compliance. This is compounded by a cluster of large, near-complete insider exits at Johnson Controls-Hitachi Air Conditioning and Adishakti Loha & Ispat, alongside promoter stake reductions at Bacil Pharma and Suncare Traders. The period-over-period data from Home First Finance shows strong asset growth (24.9% YoY) but with key warning lights flashing on asset quality (NPA up 10 bps) and declining ROE (down 80 bps). A significant theme of low-ball open offers continues, with Rekvina Labs’ offer at a 73% discount to market price, a tactic that demands regulatory scrutiny. While Bharti Airtel’s credit rating upgrade (to BBB+) offers a positive tech/telco signal, the digest is dominated by negative capital allocation and fraud risk themes.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — June 24, 2026

The four filings from Dow 30 constituents today present a quiet but strategically important picture for the index. The two new filings from Goldman Sachs and Disney are low in materiality, with Goldman's 8-K being a routine capital securities update and Disney's Form 4 revealing a routine insider transaction from a senior executive. The two JPMorgan Chase filings, while previously covered, are the most significant, with one detailing a standard capital management press release and the other confirming the release of the company's 2026 Dodd-Frank Act Stress Test (DFAST) results. The overarching theme is one of regulatory compliance and standard corporate governance, with no major period-over-period financial surprises or dramatic guidance changes. The key development is the DFAST release, which, while not providing specific quantitative results in the filing, is a critical regulatory event that will shape JPMorgan's capital return plans. The portfolio-level pattern is a lull in major operational updates, with the focus on capital structure and insider activity, suggesting a period of consolidation for these financial and entertainment giants.

1 high priority 3 medium 4 total filings
· daily

US SEC Filings Daily Market Digest — June 24, 2026

Today's filings reveal a market bifurcated between aggressive growth plays and defensive capital management. The standout is Cerebras Systems, which reported a 94.4% YoY revenue surge and a narrowing net loss, signaling strong AI chip demand. Conversely, C3.ai's 36% revenue decline and collapsing margins highlight severe headwinds in the enterprise AI space. A wave of capital market activity is underway, with SK hynix filing for a major US IPO and two new SPACs (Hoya Acquisition, Capstone 72) registering for offerings. M&A is active, with Green Dot's merger receiving overwhelming shareholder approval and Selectis Health agreeing to a take-private deal. Insider activity is sparse but notable, with a director purchase at Seaport Therapeutics. Capital allocation trends are mixed: Bradesco declared a large interim dividend, while Nuwellis and Triller executed reverse stock splits, signaling financial distress. The overarching theme is a flight to quality, with investors rewarding companies that demonstrate clear growth and profitability while punishing those with deteriorating fundamentals.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — June 24, 2026

The single filing in this stream is an insider purchase by a Ford Motor Company director, which is a modestly positive signal for the stock. There are no period-over-period trends, forward-looking statements, capital allocation changes, or transaction details to synthesize at the portfolio level. The insider buying suggests confidence from the board, but the materiality is low given the small size relative to market cap. The Consumer Discretionary sector, particularly automotive, faces headwinds from macro uncertainty, but this isolated insider activity provides a tactical data point for Ford investors. No broader sector themes can be derived from a single filing.

1 medium 1 total filings
· daily

US Earnings Financial Results SEC Filings — June 24, 2026

The 11 filings reveal a bifurcated earnings landscape for the period ending mid-2026. While revenue growth is present in select high-growth tech (Cerebras +94% YoY) and industrial turnaround stories (Daktronics +11% YoY), a broader theme of margin compression and operational strain is evident across the portfolio. Consumer-facing and enterprise software companies like CarMax and C3.ai are experiencing profit erosion despite top-line shifts, with CarMax's gross margin contracting 110 bps and C3.ai's collapsing 30 percentage points. The most critical development is the severe cash burn and reliance on dilutive financing at Cerebras, juxtaposed against its explosive revenue growth, creating a high-risk/high-reward profile. A notable portfolio-level pattern is the prevalence of 'mixed' sentiment (6 out of 11 filings), indicating that even companies showing improvement in one metric (e.g., net income) are facing headwinds in others (e.g., declining sales or cash flow). Insider activity is sparse across these filings, but the lack of insider buying at depressed levels at C3.ai and CNBX is a subtle bearish signal. Forward-looking data is limited, but the scheduled events for CarMax and John Wiley & Sons will be key catalysts for assessing consumer health and publishing sector trends.

11 high priority 11 total filings
· daily

US Executive Compensation Proxy SEC Filings — June 24, 2026

This digest of 11 proxy filings reveals a market at a clear inflection point, with companies pursuing aggressive restructuring and M&A to unlock value, while others demonstrate robust operational execution. The most critical developments are the dissolution of Getaround (a total capital loss) and the transformative mergers involving Modiv Industrial and Axalta Coating Systems, which signal a wave of consolidation. Period-over-period data highlights a stark divergence: Commvault achieved record revenue of $1.184B and returned $446M to shareholders, while 8x8 posted its first GAAP profit in a decade, contrasting with Getaround's zero-revenue state. Insider activity is notably absent across the set, but forward-looking statements point to major catalysts like Flex's spin-off and Birchtech's share reduction. Capital allocation trends show a mix of aggressive share repurchases (Commvault) and strategic M&A, with governance concerns flagged by Allspring's trustee retirements. The overall sentiment is mixed, with high materiality events concentrated in dissolution and merger proposals, demanding immediate investor attention.

11 high priority 11 total filings
· daily

US IPO Pipeline SEC S-1 Filings — June 24, 2026

The IPO pipeline on June 24, 2026, features three filings: iSpecimen Inc., a biospecimen provider with deteriorating revenue and going-concern doubts; Liminatus Pharma, a pre-revenue biotech with heavy related-party debt; and Hoya Acquisition Corp. I, a blank-check SPAC with no operational history. iSpecimen's period comparisons reveal a sharp 79% YoY revenue decline and widening quarterly losses, signaling financial distress. Liminatus carries a $112M accumulated deficit and no disclosed revenue, raising viability concerns. Hoya's SPAC structure offers a speculative IPO opportunity but carries standard blank-check risks. Overall, the pipeline lacks high-quality issuers, with negative sentiment dominating (2 negative, 1 neutral), suggesting a cautious market reception for new listings.

4 high priority 4 total filings
· daily

US SEC Trading Suspension Halt Orders — June 24, 2026

The three filings in this digest all involve US-listed companies facing severe delisting or trading suspension risks, underscoring a broader trend of micro-cap and small-cap distress. SRx Health Solutions (SRXH) is in a trading halt on NYSE American and has announced a 1-for-60 reverse stock split to regain compliance, but faces a high risk of delisting if the split fails to lift its stock price. Aditxt (ADTX) has received a final delisting determination from Nasdaq, with trading suspended effective June 25, 2026, after failing both the Bid Price Rule and Stockholders' Equity Requirement—its seventh reverse split attempt failed to maintain compliance. Definitive Healthcare (DH) received a non-compliance notice for the bid price rule but has a 180-day cure period and no immediate trading halt, making it the least acute of the three. Period-over-period data from the enriched filings reveals that all three companies have negative sentiment and no insider buying, while Aditxt's equity has deteriorated to -$35.2 million, a massive decline from the $2.5 million minimum. The key theme is a wave of reverse stock splits failing to cure structural compliance issues, signaling that these companies face fundamental business challenges beyond just low stock prices.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — June 24, 2026

The 21 filings reveal a significant wave of executive departures and governance shifts, particularly in the technology and healthcare sectors. We identified 8 officer resignations or retirements (CFOs, CLOs, CGOs, President, CEO) and 3 director changes across the portfolio. Notably, no insider buying was reported, but several departures are tied to restructuring, suggesting cost optimization pressures. Forward-looking data indicates a rebuilding phase, with 4 companies actively searching for successors and several others implementing workforce realignments and equity plan expansions to retain talent. The most critical developments include Elastic N.V.'s 7% workforce reduction combined with a CPO resignation, Grove Collaborative's CFO resignation amid significant broker non-votes, and HeartBeam's strategic pivot to a licensing model with a CEO transition. Period-over-period data, though limited, shows a pattern of operational streamlining and strategic repositioning across firms.

21 high priority 21 total filings